Evidence that blood–CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with migraine frequency and CSF fibrinogen

OBJECTIVE: Our objective is to explore whether blood–cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls. BACKGROUND: Reports of blood–brain barrier and blood–cerebrospinal fluid barrier (BCSFB) disruption in migraine vary. Our hypothe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Headache
Egile Nagusiak: Cowan, Robert P., Gross, Noah B., Sweeney, Melanie D., Sagare, Abhay P., Montagne, Axel, Arakaki, Xianghong, Fonteh, Alfred N., Zlokovic, Berislav V., Pogoda, Janice M., Harrington, Michael G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Research Submissions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8023403/
https://ncbi.nlm.nih.gov/pubmed/33724462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14088
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak